Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification

B Meeusen, V Janssens - The international journal of biochemistry & cell …, 2018 - Elsevier
Aberrant protein phosphorylation is one of the hallmarks of cancer cells, and in many cases
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …

Updates in glioblastoma immunotherapy: an overview of the current clinical and translational scenario

A Bianconi, G Palmieri, G Aruta, M Monticelli, P Zeppa… - Biomedicines, 2023 - mdpi.com
Glioblastoma (GBM) is the most common and aggressive central nervous system tumor,
requiring multimodal management. Due to its malignant behavior and infiltrative growth …

[HTML][HTML] miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas

J Liu, J Xu, H Li, C Sun, L Yu, Y Li, C Shi, X Zhou… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Down-regulation of miR-146b-5p contributes to tumorigenesis in several human cancers.
However, the relevance of miR-146b-5p to prognosis, proliferation and apoptosis in gliomas …

The role of cytoreductive surgery in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline

TC Ryken, SN Kalkanis, JM Buatti, JJ Olson - Journal of neuro-oncology, 2014 - Springer
Question Should patients with previously diagnosed malignant glioma who are suspected of
experiencing progression of the neoplasm process undergo repeat open surgical resection …

Genomic, epigenomic and transcriptomic landscape of glioblastoma

TC Dakal, GS Kakde, PK Maurya - Metabolic Brain Disease, 2024 - Springer
The mostly aggressive and extremely malignant type of central nervous system is
Glioblastoma (GBM), which is characterized by an extremely short average survival time of …

The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer

LS Chang, M Kim, A Glinka, C Reinhard, C Niehrs - Elife, 2020 - elifesciences.org
A hallmark of Spemann organizer function is its expression of Wnt antagonists that regulate
axial embryonic patterning. Here we identify the tumor suppressor Protein tyrosine …

[HTML][HTML] Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies

O Keunen, T Taxt, R Grüner, M Lund-Johansen… - Advanced drug delivery …, 2014 - Elsevier
The vast majority of malignant gliomas relapse after surgery and standard radio-
chemotherapy. Novel molecular and cellular therapies are thus being developed, targeting …

[HTML][HTML] Silencing of lncRNA CCDC26 restrains the growth and migration of glioma cells in vitro and in vivo via targeting miR-203

S Wang, Y Hui, X Li, Q Jia - Oncology Research, 2018 - ncbi.nlm.nih.gov
Gliomas are the most common primary brain tumors with high mortality. The treatment for
gliomas is largely limited due to its uncomprehending pathological mechanism. Here we …

Glioblastoma genomics: a very complicated story

MY Lombardi, M Assem - Exon Publications, 2017 - exonpublications.com
Glioblastoma is a deadly disease that has not shown improvement despite the development
of new diagnostic tools and innovative targeted therapies. This grim outcome is mainly …

The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity

PH Chen, WL Shen, CM Shih, KH Ho, CH Cheng… - …, 2017 - Elsevier
Glioblastoma multiforme (GBM) is the high-grade primary glioma in adults. Temozolomide
(TMZ), an alkylating agent of the imidazotetrazine series, is a first-line chemotherapeutic …